| Product dosage: 300mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.87 | $52.48 (0%) | 🛒 Add to cart |
| 90 | $0.80 | $78.72 $71.65 (9%) | 🛒 Add to cart |
| 120 | $0.75 | $104.95 $89.82 (14%) | 🛒 Add to cart |
| 180 | $0.71 | $157.43 $127.16 (19%) | 🛒 Add to cart |
| 270 | $0.68 | $236.15 $183.67 (22%) | 🛒 Add to cart |
| 360 | $0.67
Best per pill | $314.86 $240.18 (24%) | 🛒 Add to cart |
Synonyms
| |||
Similar products
More info:
allopurinol
Allopurinol is a xanthine oxidase inhibitor, a medication that fundamentally alters the body’s production of uric acid. It’s not a painkiller; it’s a corrective agent for a metabolic error. We use it for chronic gout, but its role has expanded into managing hyperuricemia secondary to cancer treatments and certain types of kidney stones. It’s one of those workhorse drugs that’s been around for decades, precisely because it works on a clear, single pathway.
aceon
Perindopril erbumine, marketed under the brand name Aceon, represents a significant advancement in the angiotensin-converting enzyme (ACE) inhibitor class. This medication has become a cornerstone in managing hypertension and reducing cardiovascular risk, particularly following myocardial infarction. Unlike many dietary supplements, Aceon undergoes rigorous pharmaceutical testing and standardization, making its dosing predictable and its effects well-characterized in clinical literature. Its mechanism—primarily through inhibition of angiotensin I to angiotensin II conversion—creates a cascade of hemodynamic benefits that we’ll explore in depth.
ampicillin
A broad-spectrum penicillin antibiotic derived from the basic penicillin nucleus, ampicillin represents a significant advancement in antimicrobial therapy due to its activity against both gram-positive and gram-negative organisms. Unlike earlier penicillins, its extended spectrum made it particularly valuable for treating common bacterial infections before resistance patterns shifted. The drug works by inhibiting bacterial cell wall synthesis, specifically targeting the transpeptidase enzymes responsible for cross-linking peptidoglycan chains, which ultimately leads to bacterial cell lysis and death.
benemid
Benemid represents one of those interesting cases where an older medication finds renewed relevance through modern understanding of pharmacokinetics. Originally developed in the 1950s, probenecid—the active pharmaceutical ingredient in Benemid—has maintained its place in therapeutic arsenals despite the constant churn of new drug development. What’s fascinating is how its mechanism, once viewed as somewhat niche, actually intersects with multiple physiological pathways we’re only now fully appreciating. The drug exists in this interesting space between a traditional pharmaceutical and what some might consider almost a metabolic adjunct.
capoten
Capoten, known generically as captopril, represents one of the foundational pillars in modern cardiovascular pharmacotherapy. As the first orally active angiotensin-converting enzyme (ACE) inhibitor approved for clinical use, it fundamentally reshaped hypertension and heart failure management protocols. Unlike earlier antihypertensives that often caused significant side effects, Capoten offered a targeted mechanism that directly interfered with the renin-angiotensin-aldosterone system, providing clinicians with a more physiologic approach to blood pressure control and afterload reduction.
cenmox
Cenmox represents one of those interesting developments in clinical practice where you see something transition from theoretical promise to practical utility. It’s a high-potency amoxicillin formulation with clavulanate potassium, but what makes it distinctive isn’t just the antibiotic components themselves—it’s the delivery system and concentration that create its clinical profile. When we first started working with this formulation back in 2018, I was skeptical about whether another amoxicillin-clavulanate product was really necessary, but the pharmacokinetic data caught my attention.
Colchicine: Targeted Anti-Inflammatory Therapy for Crystal Arthropathies - Evidence-Based Review
Colchicine is a plant-derived alkaloid medication originally extracted from the autumn crocus (Colchicum autumnale). It’s one of medicine’s oldest continuously used drugs, with references dating back to ancient Egyptian times. Today, it’s primarily prescribed for its potent anti-inflammatory effects in conditions like gout and familial Mediterranean fever, though recent research has expanded its potential applications significantly. What makes colchicine particularly interesting is its unique mechanism—it doesn’t work like typical NSAIDs or steroids but targets microtubules and inflammatory pathways at a cellular level.
Coversyl: Effective Blood Pressure Control and Cardiovascular Protection - Evidence-Based Review
Perindopril, marketed under the brand name Coversyl, is an angiotensin-converting enzyme (ACE) inhibitor prescribed primarily for the management of hypertension and heart failure. It works by blocking the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, thereby promoting vasodilation and reducing blood pressure. Available in various strengths, typically 2mg, 4mg, and 8mg tablets, it’s a cornerstone in cardiovascular therapy due to its proven efficacy in improving outcomes in patients with coronary artery disease and post-myocardial infarction.
Cystone: Comprehensive Urinary Tract and Kidney Stone Support - Evidence-Based Review
Cystone represents one of those interesting botanical formulations that sits right at the intersection of traditional medicine and modern clinical practice. It’s not your typical single-compound pharmaceutical, but rather a sophisticated blend of herbal extracts specifically designed for urinary system support. What makes Cystone particularly compelling is its multi-target approach - rather than hitting one pathway like many synthetic drugs, it works through several complementary mechanisms to support kidney and urinary tract health.